Strong momentum in GC&MP, headwinds in NW&FT and FW '25e-'27e sales CAGR of +14% New product launche...
Expect continued M&A, mainly in DACH 5% adj. EBITA CAGR '24-'27e, M&A to support 10% growth 10-7x EB...
Scibase is steadily executing on its long-term strategy, with the US and Germany continuing to drive...
EQL Pharma presterar starkt och visar upp en väl tilltagen omsättningstillväxt i kombination med god...
VibroSense redovisade en nettoomsättning om 0,75 MSEK (0,47) i kvartalet, vilket var en ökning med 5...
The new CEO, Renee Aguiar-Lucander, has signed Maria Törnsén as COO and president of the US operatio...
Den 12 maj 2025 meddelade AcuCort (”AcuCort” eller ”Bolaget”) att Bolaget mottagit en ny order på Ze...
ByggPartnerGruppen levererade en stark rapport där orderingången närapå dubblades.
Redeye notes that Smart Eye’s Q1 reflected mixed performance due to weaker than expected sales in bo...
Relais reported Q1 adjusted EBITA of EUR 9.2m was down 5% y/y, in line with LSEG Data & Analytics co...
Net sales of SEK67.7m were almost SEK9m higher than expected.
Net sales and EBITDA without insurance compensation were broadly in line with our expectations for Q...
Q1 likely solid, Q2 comments on activity in focus We expect FY guidance to be reiterated EBITA -3-4%...
Stabilt, stabilare, EQL Pharma Nettoomsättningen ökade med imponerande 45,0 %, främst drivet av tidi...
Redeye provides a brief comment following Alzinova’s announcement of the outcome of its SEK35.
